Tatva Chintan Pharma Chem Limited (NSE:TATVA)
India
· Delayed Price · Currency is INR 1,151.50
+55.90 (5.10%)
Mar 10, 2026, 12:10 PM IST
Tatva Chintan Pharma Chem Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2018 |
| Market Capitalization | 25,628 | 15,840 | 25,231 | 36,995 | 51,166 | - | Upgrade
|
| Market Cap Growth | 57.58% | -37.22% | -31.80% | -27.70% | - | - | Upgrade
|
| Enterprise Value | 26,287 | 15,844 | 24,403 | 37,505 | 50,113 | - | Upgrade
|
| Last Close Price | 1095.60 | 676.48 | 1075.32 | 1661.94 | 2296.74 | - | Upgrade
|
| PE Ratio | 78.16 | 277.26 | 83.12 | 81.33 | 53.37 | - | Upgrade
|
| Forward PE | 41.76 | 41.06 | 29.94 | 36.07 | 42.29 | - | Upgrade
|
| PS Ratio | 5.34 | 4.14 | 6.41 | 8.73 | 11.80 | - | Upgrade
|
| PB Ratio | 3.40 | 2.14 | 3.42 | 7.19 | 10.82 | - | Upgrade
|
| P/TBV Ratio | 3.43 | 2.16 | 3.44 | 7.19 | 10.82 | - | Upgrade
|
| P/OCF Ratio | - | 64.21 | 25.73 | 133.16 | 252.92 | - | Upgrade
|
| EV/Sales Ratio | 5.48 | 4.14 | 6.20 | 8.85 | 11.56 | - | Upgrade
|
| EV/EBITDA Ratio | 39.14 | 47.71 | 35.40 | 55.46 | 46.26 | - | Upgrade
|
| EV/EBIT Ratio | 66.77 | 237.11 | 55.74 | 64.15 | 49.87 | - | Upgrade
|
| Debt / Equity Ratio | 0.11 | 0.05 | 0.02 | 0.33 | 0.25 | 0.54 | Upgrade
|
| Debt / EBITDA Ratio | 1.24 | 1.09 | 0.21 | 2.51 | 1.10 | 1.35 | Upgrade
|
| Net Debt / Equity Ratio | 0.09 | 0.03 | -0.04 | 0.25 | 0.12 | 0.51 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.98 | 0.74 | -0.45 | 1.91 | 0.52 | 1.27 | Upgrade
|
| Net Debt / FCF Ratio | - | -0.48 | 1.03 | -0.74 | -0.81 | -66.66 | Upgrade
|
| Asset Turnover | - | 0.46 | 0.50 | 0.60 | 0.89 | 1.07 | Upgrade
|
| Inventory Turnover | - | 1.44 | 1.16 | 1.40 | 1.67 | 2.32 | Upgrade
|
| Quick Ratio | - | 1.07 | 1.48 | 0.54 | 0.73 | 0.84 | Upgrade
|
| Current Ratio | - | 2.76 | 3.74 | 1.31 | 2.55 | 1.56 | Upgrade
|
| Return on Equity (ROE) | - | 0.77% | 4.85% | 9.21% | 30.00% | 36.85% | Upgrade
|
| Return on Assets (ROA) | - | 0.51% | 3.47% | 5.16% | 12.91% | 13.34% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.71% | 0.69% | 4.52% | 9.97% | 23.72% | 23.21% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 0.90% | 5.90% | 11.20% | 20.60% | 30.60% | Upgrade
|
| Earnings Yield | 1.28% | 0.36% | 1.20% | 1.23% | 1.87% | - | Upgrade
|
| FCF Yield | - | -3.26% | -1.21% | -4.74% | -1.35% | - | Upgrade
|
| Dividend Yield | 0.09% | 0.15% | 0.19% | 0.12% | 0.09% | - | Upgrade
|
| Payout Ratio | - | 81.88% | 15.41% | 9.75% | - | 7.69% | Upgrade
|
| Buyback Yield / Dilution | 0.19% | -2.20% | -3.27% | -3.10% | -7.03% | - | Upgrade
|
| Total Shareholder Return | 0.27% | -2.05% | -3.08% | -2.98% | -6.94% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.